BRIEF-Zepp Health Corp QTRLY Revenue $42.5 Million

Reuters11-19

Nov 19 (Reuters) - Zepp Health Corp :

* ZEPP HEALTH CORP: QTRLY REVENUE $42.5 MILLION

* ZEPP HEALTH CORP: OUTLOOK Q4 NET REVENUE TO BE BETWEEN $55 MILLION AND $70 MILLION

* ZEPP HEALTH CORP: QTRLY ADJUSTED NET LOSS PER ADS $0.78

* ZEPP HEALTH CORP: ON NOV 18, BOARD FURTHER AUTHORIZED CO TO EXTEND ITS SHARE REPURCHASE PROGRAM FOR ANOTHER 24 MONTHS

* ZEPP HEALTH CORP: QTRLY ADJUSTED NET LOSS PER SHARE $0.05

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2484914769?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-19 19:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484914769","market":"sh","top_or_hot":-1,"title":"BRIEF-Zepp Health Corp QTRLY Revenue $42.5 Million","media":"Reuters","content":"<html><body><p>Nov 19 (Reuters) - Zepp Health Corp   :</p><p>   * ZEPP HEALTH CORP: QTRLY REVENUE $42.5 MILLION</p><p>   * ZEPP HEALTH CORP: OUTLOOK Q4 NET REVENUE TO BE BETWEEN $55 MILLION AND $70 MILLION</p><p>   * ZEPP HEALTH CORP: QTRLY ADJUSTED NET LOSS PER ADS $0.78</p><p>   * ZEPP HEALTH CORP:  ON NOV 18, BOARD FURTHER AUTHORIZED CO TO EXTEND ITS SHARE REPURCHASE PROGRAM FOR ANOTHER 24 MONTHS</p><p>   * ZEPP HEALTH CORP: QTRLY ADJUSTED NET LOSS PER SHARE $0.05</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Zepp Health Corp QTRLY Revenue $42.5 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Zepp Health Corp QTRLY Revenue $42.5 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-19 19:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 19 (Reuters) - Zepp Health Corp   :   * ZEPP HEALTH CORP: QTRLY REVENUE $42.5 MILLION   * ZEPP HEALTH CORP: OUTLOOK Q4 NET REVENUE TO BE BETWEEN $55 MILLION AND $70 MILLION   * ZEPP HEALTH CORP: ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ZEPP","symbol_name":"华米科技","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2484914769","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484914769","pubTimestamp":1732015272,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 19  - Zepp Health Corp   :   * ZEPP HEALTH CORP: QTRLY REVENUE $42.5 MILLION   * ZEPP HEALTH CORP: OUTLOOK Q4 NET REVENUE TO BE BETWEEN $55 MILLION AND $70 MILLION   * ZEPP HEALTH CORP: QTRLY ADJUSTED NET LOSS PER ADS $0.78   * ZEPP HEALTH CORP:  ON NOV 18, BOARD FURTHER AUTHORIZED CO TO EXTEND ITS SHARE REPURCHASE PROGRAM FOR ANOTHER 24 MONTHS   * ZEPP HEALTH CORP: QTRLY ADJUSTED NET LOSS PER SHARE $0.05Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ZEPP":"华米科技"},"translate_title":"简介-Zepp Health Corp季度收入4250万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ZEPP":0.9},"content_text":"Nov 19 (Reuters) - Zepp Health Corp   :   * ZEPP HEALTH CORP: QTRLY REVENUE $42.5 MILLION   * ZEPP HEALTH CORP: OUTLOOK Q4 NET REVENUE TO BE BETWEEN $55 MILLION AND $70 MILLION   * ZEPP HEALTH CORP: QTRLY ADJUSTED NET LOSS PER ADS $0.78   * ZEPP HEALTH CORP:  ON NOV 18, BOARD FURTHER AUTHORIZED CO TO EXTEND ITS SHARE REPURCHASE PROGRAM FOR ANOTHER 24 MONTHS   * ZEPP HEALTH CORP: QTRLY ADJUSTED NET LOSS PER SHARE $0.05Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484914769"}